Dr. Christine Debouck manages the Division of Genomic & Proteomic Sciences in the Genetics Research Directorate at GlaxoSmithKline. She manages about 200 laboratory scientists working in a transnational setting and conducting cutting edge functional genomics for drug discovery and drug development. She was appointed Senior Vice President of Genomic & Proteomic Sciences after assuming positions of increasing responsibility within the organization, beginning with her post-doctoral work with the former SmithKline & French Laboratories. She also conducted post-doctoral work with the National Cancer Institute and the National Institutes of Health, working on the regulation of gene expression.

Dr. Debouck received her bachelor's and master's degrees in Zoology-Molecular Biology, summa cum laude from the University of Brussels-Belgium, Department of Genetics. She also earned her Ph.D. summa cum laude from the University of Brussels–Belgium where she studied the regulation of prokaryotic transcription and translation. Dr. Debouck has made significant contributions as a bench scientist to the field of HIV and was the first to submit a report on the identification of the HIV protease and its proteolytic activity. She has recently driven applications of high throughput gene discovery to the identification of novel therapeutic targets, and has integrated functional genomics into the drug discovery and drug development activities. She has authored 112 publications and holds 16 issued patents.